Business Context and Reporting Period
This Form 8-K filing by Histogenics Corporation (trading symbol HSGX) was submitted on October 18, 2018, reporting an event that occurred on October 17, 2018. The company is incorporated in Delaware and operates as an emerging growth company.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the stock price performance triggering the regulatory notice.
Material Changes
On October 17, 2018, the company received a deficiency letter from the Nasdaq Listing Qualifications Department. The notice states that for the last 30 consecutive business days, the closing bid price of the company's common stock has been below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market under Rule 5550(a)(2).
Outlook, Risks, and Contingencies
- Compliance Period: The company has been granted 180 calendar days, until April 15, 2019, to regain compliance with the minimum bid price requirement.
- Remediation Options: The company may regain compliance if the stock closes at $1.00 or more for 10 consecutive business days (Automatic Compliance Event) or by implementing a reverse stock split no later than ten business days prior to the April 15, 2019 deadline.
- Delisting Risk: If compliance is not achieved by April 15, 2019, and the company is not eligible for a second compliance period, the stock will be subject to delisting. A second period is possible if the company meets market value and other initial listing standards.
- Appeal Process: If delisting is imminent, the company may appeal the determination to a Nasdaq Listing Qualifications Panel while remaining listed pending the decision.
Investor Verification Checklist
- Verify the current closing bid price of HSGX stock to assess proximity to the $1.00 threshold.
- Monitor company announcements regarding the potential implementation of a reverse stock split.
- Review the company's market value of publicly held shares to determine eligibility for a second compliance period if the initial deadline is missed.
- Check for any subsequent filings regarding the status of the deficiency letter or an Automatic Compliance Event.